Study design and participants
NAFLD
MAESTRO-NAFLD-1 (ClinicalTrials.gov identifier Male and female adults ≥18 years of age with ≥3 metabolic risk factors could screen for inclusion in MAESTRO-NAFLD-1. At sites participating in MAESTRO-NASH, patients who failed the screen for MAESTRO-NASH but had confirmed NAFLD (earlier stage or F2/F3 with NAFLD activity score (NAS) < 4) could enroll in MAESTRO-NAFLD and patients with FibroScan VCTE LSM ≥ 5.5 and <8.5 kPa and FibroScan CAP ≥ 280 dB m